The essential feature of this renewal continues to be a collaborative basic neurobiological and clinical research endeavor working toward elucidation of the neurobiological factors in the genesis and treatment of major psychiatric disorders. The proposed research program consists of both preclinical and clinical projects concerned with studying the mechanisms of action of psychotropic drugs and possible biological determinants in schizophrenia and affective illness, through the use of anatomical, histochemical, biochemical, neurophysiological, and behavioral techniques. Preclinical studies relevant to schizophrenia address the effects of both acute and chronic antipsychotic drug treatment on monoaminergic systems and the effect of acute and chronic L-dopa or apomorphine administration on dopaminergic, noradrenergic and serotonergic systems. The clincial section extends to human questions being addressed at a basic level in animals. In clinical studies of schizophrenia the effects of acute, chronic and long-term neuroleptic treatment on serotonergic, noradrenergic and dopaminergic systems will be studied. In studies of the affective disorder particular attention will be paid to systems implicated in the """"""""monoaminergic theory of affective illness"""""""" by studying: the effect of chronic administration of tricyclic antidepressant drugs on postsynaptic receptor sensitivity using single-cell techniques; by agonist-induced changes in acoustic startle amplitude as a measure of postsynaptic receptor sensitivity following chronic administration of antidepressant drugs; possible reversal of the effects of chronic locus coeruleus stimulation by chronic antidepressant treatment; the effects of monoaminergic neurotransmission on electrically induced neurophysiological reflexes and the effect of administration of tricyclic antidepressant drugs on such effects; the effects of chronic drugs on clonidine induced changes in hormonal function in animals; and prospective clinical application of the findings which emerge from basic animal studies. Included also will be development of methods relevant to assessment of function of central monoaminergic systems in patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program Projects (P01)
Project #
5P01MH025642-16
Application #
3099003
Study Section
(SRCM)
Project Start
1978-07-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
16
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Voleti, Bhavya; Navarria, Andrea; Liu, Rong-Jian et al. (2013) Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry 74:742-9
Duric, Vanja; Banasr, Mounira; Stockmeier, Craig A et al. (2013) Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol 16:69-82
Duric, Vanja; Duman, Ronald S (2013) Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci 70:39-53
Newton, Samuel S; Fournier, Neil M; Duman, Ronald S (2013) Vascular growth factors in neuropsychiatry. Cell Mol Life Sci 70:1739-52
Fournier, Neil M; Lee, Boyoung; Banasr, Mounira et al. (2012) Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling. Neuropharmacology 63:642-52
Fournier, Neil M; Duman, Ronald S (2012) Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression. Behav Brain Res 227:440-9
Son, Hyeon; Banasr, Mounira; Choi, Miyeon et al. (2012) Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress. Proc Natl Acad Sci U S A 109:11378-83
Voleti, Bhavya; Tanis, Keith Q; Newton, Samuel S et al. (2012) Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression. Biol Psychiatry 71:51-8
Kang, Hyo Jung; Voleti, Bhavya; Hajszan, Tibor et al. (2012) Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 18:1413-7
Li, Nanxin; Liu, Rong-Jian; Dwyer, Jason M et al. (2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69:754-61

Showing the most recent 10 out of 389 publications